Meanwhile, subcellular fractionation assay also showed Lexa and CHX combination treatment induced cytochrome c release in HCC cells, whereas, NAC addition significantly could block this process (Fig. 6C). The gene discussed is CYCS; the disease is hepatocellular carcinoma.